{"id":42461,"date":"2018-10-11T12:42:17","date_gmt":"2018-10-11T10:42:17","guid":{"rendered":"https:\/\/newserver.fyb.de\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/"},"modified":"2018-10-11T12:42:17","modified_gmt":"2018-10-11T10:42:17","slug":"ardian-acquires-majority-stake-in-natural-therapies-provider-inula","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/","title":{"rendered":"Ardian acquires majority stake in natural therapies provider INULA"},"content":{"rendered":"

Paris \u2014 Ardian<\/strong>, one of the worl\u00add\u2019s leading inde\u00adpen\u00addent invest\u00adment firms, has ente\u00adred into an agree\u00adment to acquire a majo\u00adrity stake in Inula Group<\/strong> with Vendis Capi\u00adtal, Domi\u00adni\u00adque Baudoux<\/strong> (Foun\u00adder and Chair\u00adman) and Sergio Calan\u00addri<\/strong> (CEO).<\/p>\n

The Inula Group<\/strong> was formed from the merger of Pran\u00adar\u00f4m and Herbal\u00adGem, two pioneers in the field of natu\u00adral thera\u00adpies. The two labo\u00adra\u00adto\u00adries were estab\u00adlished in 1985 and 1986, respec\u00adtively. Today, Inula is a leading provi\u00adder of herbal reme\u00addies. With the brands Pran\u00adar\u00f4m, Herbal\u00adGem and Bioflo\u00adral, the Group specia\u00adli\u00adzes in parti\u00adcu\u00adlar in the high-growth segments of aroma\u00adthe\u00adrapy, gemmo\u00adthe\u00adrapy and Bach flower reme\u00addies. Thanks to the company\u2019s scien\u00adti\u00adfic approach and the quality of its products, the group has seen signi\u00adfi\u00adcant growth in recent years. Today it opera\u00adtes in 25 count\u00adries and has a leading posi\u00adtion in the markets of France, Belgium, Spain, Italy and the USA.<\/p>\n

As part of this tran\u00adsac\u00adtion, the Group\u2019s CEO, Sergio Calan\u00addri, reinvests along\u00adside Ardian. Vendis Capi\u00adtal and Pran\u00adar\u00f4m foun\u00adder Domi\u00adni\u00adque Baudoux may also conti\u00adnue to support the group.<\/p>\n

Bruno Ladri\u00e8re, Mana\u00adging Direc\u00adtor of Ardian Buyout, and Daniel Setton, Direc\u00adtor, stated: \u201cWe are very much looking forward to working with Inula\u2019s teams and thank them for the trust they have placed in us as part of this tran\u00adsac\u00adtion. Toge\u00adther we will support the contin\u00adued growth of the company and expand the market posi\u00adtion of Pran\u00adar\u00f4m, Herbal\u00adGem and Bioflo\u00adral in Europe and globally. With this tran\u00adsac\u00adtion, we under\u00adline our stra\u00adtegy to support mid-sized compa\u00adnies in reali\u00adzing their growth opportunities.\u201d<\/p>\n

For their part, Cedric Olbrechts, part\u00adner at Vendis Capi\u00adtal, and Domi\u00adni\u00adque Baudoux, foun\u00adder and chair\u00adman of Inula, said: \u201cDuring the seven-year part\u00adner\u00adship between Vendis and Inula, we have been able to create a great dyna\u00admic for the company, combi\u00adning our expe\u00adri\u00adence and exper\u00adtise. Today, the group is the leading provi\u00adder of natu\u00adral reme\u00addies in Europe. It has signi\u00adfi\u00adcantly expan\u00added its inter\u00adna\u00adtio\u00adnal presence, added new distri\u00adbu\u00adtion chan\u00adnels and deve\u00adlo\u00adped new products through the Pran\u00adar\u00f4m brand and the successful inte\u00adgra\u00adtion of Herbal\u00adGem, Bioflo\u00adral and Veri\u00addi\u00adtas. We are proud that we have been able to successfully imple\u00adment the objec\u00adti\u00adves set in 2011. These succes\u00adses are prima\u00adrily due to the compe\u00adtent and expe\u00adri\u00aden\u00adced manage\u00adment team led by Sergio Calan\u00addri. We would like to express our sincere thanks here to ever\u00adyone for their dedi\u00adca\u00adtion and excel\u00adlent work.\u201d Domi\u00adni\u00adque Baudoux added: \u201cIt was quickly clear to me that Ardian was the right part\u00adner for us and that the team shares our values, which have driven the success of our group since its inception.\u201d<\/p>\n

Sergio Calan\u00addri, CEO of Inula, added: \u201cIn recent years, our Group has deve\u00adlo\u00adped extre\u00admely stron\u00adgly. We have been able to estab\u00adlish our brands as market leaders in seve\u00adral count\u00adries in Europe and world\u00adwide and have successfully inte\u00adgra\u00adted our acqui\u00adsi\u00adti\u00adons. Our future growth is built on the elements that charac\u00adte\u00adrize our approach: The quality of our products, a scien\u00adti\u00adfic approach, exten\u00adsive trai\u00adning and mastery of all stages of manu\u00adfac\u00adtu\u00adring. Ardian, with exten\u00adsive expe\u00adri\u00adence in the health\u00adcare sector and its inter\u00adna\u00adtio\u00adnal network, is the ideal part\u00adner to accom\u00adpany Inula\u2019s growth in the coming years.\u201d<\/p>\n

About Ardian<\/strong>
\nArdian is one of the worl\u00add\u2019s leading inde\u00adpen\u00addent invest\u00adment firms, mana\u00adging appro\u00adxi\u00adm\u00adately US$72 billion in assets on behalf of its inves\u00adtors from Europe, South and North America and Asia. The company is majo\u00adrity-owned by its employees and gene\u00adra\u00adtes sustainable, attrac\u00adtive returns for its inves\u00adtors. With the objec\u00adtive of achie\u00adving posi\u00adtive results for all stake\u00adhol\u00adders, Ardian\u2019s acti\u00advi\u00adties promote indi\u00advi\u00addu\u00adals, compa\u00adnies and econo\u00admies world\u00adwide. Ardian\u2019s invest\u00adment philo\u00adso\u00adphy is aligned with the three guiding prin\u00adci\u00adples of excel\u00adlence, loyalty and entrepreneurship.<\/p>\n

The company has a global network of more than 530 employees and 14 offices in Europe (Frank\u00adfurt, Jersey, London, Luxem\u00adbourg, Madrid, Milan, Paris and Zurich), South America (Sant\u00adiago de Chile), North America (New York and San Fran\u00adcisco) and Asia (Beijing, Singa\u00adpore and Tokyo). Ardian mana\u00adges the assets of its appro\u00adxi\u00adm\u00adately 750 inves\u00adtors in five invest\u00adment areas: Direct Funds, Funds of Funds, Infra\u00adstruc\u00adture, Private Debt and Real Estate.<\/p>\n

About Inula<\/strong>
\nThe Inula Group was formed from the merger of Pran\u00adar\u00f4m and Herbal\u00adGem, two pioneers in the field of natu\u00adral thera\u00adpies. The two labo\u00adra\u00adto\u00adries were estab\u00adlished in 1985 and 1986, respec\u00adtively. Inula deve\u00adlops, produ\u00adces and distri\u00adbu\u00adtes phyto\u00adthe\u00adra\u00adpeu\u00adtic reme\u00addies. Its three brands are market leaders in their respec\u00adtive sectors: Pran\u00adar\u00f4m in scien\u00adti\u00adfic aroma\u00adthe\u00adrapy (essen\u00adtial oils), Herbal\u00adGem in concen\u00adtra\u00adted gemmo\u00adthe\u00adrapy (bud extra\u00adcts) and Bioflo\u00adral in Bach flowers (flower extra\u00adcts). Inula achie\u00adved conso\u00adli\u00adda\u00adted sales of 85 million euros in 2017. The Group markets its products through six sales compa\u00adnies (based in Belgium, France, Spain, Italy, Portu\u00adgal and North America) and distri\u00adbu\u00adtors in more than 20 count\u00adries in Europe, Asia and North America. The products are distri\u00adbu\u00adted by more than 12,000 custo\u00admers. These include phar\u00admacies, health food stores and health profes\u00adsio\u00adnals. The group opera\u00adtes its own orga\u00adnic plan\u00adta\u00adti\u00adons and four manu\u00adfac\u00adtu\u00adring labo\u00adra\u00adto\u00adries in Belgium (Pran\u00adar\u00f4m in Ghis\u00adleng\u00adhien and Herbal\u00adGem in Viel\u00adsalm), France (Bioflo\u00adral in Auver\u00adgne) and the USA (Inula in Minnea\u00adpo\u00adlis). www.pranarom.com \u2014 www.herbalgem.com \u2014 www.biofloral.fr<\/p>\n

About Vendis Capital<\/strong>
\nFoun\u00added in 2009, Vendis Capi\u00adtal is an inde\u00adpen\u00addent private equity firm focu\u00adsed on the Euro\u00adpean consu\u00admer goods sector. Working with expe\u00adri\u00aden\u00adced entre\u00adpre\u00adneurs and mana\u00adgers, Vendis invests in small to medium-sized bran\u00added compa\u00adnies in Europe that are well posi\u00adtio\u00adned for value-crea\u00adting growth or trans\u00adfor\u00adma\u00adtion proces\u00adses. Vendis invests in France, Belgium, the Nether\u00adlands, Germany and Scan\u00addi\u00adna\u00advia. www.vendiscapital.com<\/p>\n

Compa\u00adnies and persons invol\u00adved in the transaction<\/strong>
\nSellers: Vendis Capi\u00adtal (Cedric Olbrechts, Mathieu de Medei\u00adros), Domi\u00adni\u00adque Baudoux (Foun\u00adder and Chair\u00adman), Sergio Calan\u00addri (CEO)
\nAcqui\u00adrer: Ardian (Bruno Ladri\u00e8re, Daniel Setton, Alexis Manet, Rafik Alili, Edmond Delamalle)<\/p>\n

Vendor consul\u00adtant<\/strong>
\nM&A: JP Morgan (Edouard Debost, Peter Hujoel, Sebas\u00adtien Guiol)
\nM&A Law: Fresh\u00adfields (Vincent Macq, Frede\u00adric Elens, Elliott Fosseprez)
\nLawyer of the manage\u00adment: Laurius (David Ryckaert)
\nFinan\u00adcial VDD: PwC (Phil\u00adippe Estas, Geoff\u00adroy Jonck\u00adheere, Arnaud Chan\u00adtraine, Olivier Van Crombrugge)
\nTax VDD: PwC (Hugues Lamon, Koen Walbers)
\nStra\u00adte\u00adgic VDD: Roland Berger (Gr\u00e9go\u00adire Tondreau, Patrick Bieche\u00adler, Pierre-Antoine Bodin, Jean Muraire, Yaros\u00adlav Stetsenko)
\nRegu\u00adla\u00adtory VDD: Coving\u00adton (Bart Van Vooren)<\/p>\n

Advi\u00adsor of the acquirer<\/strong>
\nM&A: BNP Pari\u00adbas Fortis (Gabriel Engle\u00adbert, Pieter-Jan Van de Walle, Wide Hellem\u00adans, Elena Coluc\u00adcelli-Gu\u00e9rin, Muriel Petit)
\nLegal advice: Latham (Olivier du Mottay, B\u00e9n\u00e9\u00addicte Bremond, Lionel Dechmann)
\nFinan\u00adcial advi\u00adsory: EY (Yannick Lostie de Kerhor, St\u00e9phane Seguin, Mathieu Creu\u00adzet, Nico\u00adlas Morel)
\nLegal, tax, social and ESG advice: EY (Jean-Chris\u00adto\u00adphe Sabou\u00adrin, Patrice Mottier, Tom Swin\u00adnen, Lionel Benant, Anne Dupu\u00adpet, Anne-Elisa\u00adbeth Combes, Maelle Duquoc).
\nInsu\u00adrance consul\u00adting: Siaci St Honor\u00e9 (Pierre de Rochebouet, Julie Marmara, Brigitte Lalo)
\nStra\u00adte\u00adgic advice: EY-Parthe\u00adnon (Henri-Pierre Vacher, Vincent Czes\u00adzyn\u00adski, Louis Ravier, Benja\u00admin Ferrand, Fabien Bouskila)
\nRegu\u00adla\u00adtory consul\u00adting: Inno\u00adveo\u00adCare (G\u00e9ral\u00addine Veuil\u00adlet, Elodie Demars)<\/p>\n","protected":false},"excerpt":{"rendered":"

Paris \u2014 Ardian, one of the worl\u00add\u2019s leading inde\u00adpen\u00addent invest\u00adment firms, has ente\u00adred into an agree\u00adment to acquire a majo\u00adrity stake in Inula Group with Vendis Capi\u00adtal, Domi\u00adni\u00adque Baudoux (Foun\u00adder and Chair\u00adman) and Sergio Calan\u00addri (CEO). The Inula Group was formed from the merger of Pran\u00adar\u00f4m and Herbal\u00adGem, two pioneers in the field of natural [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":42175,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1366],"tags":[],"class_list":["post-42461","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-news-en","news-category-private-equity-news-en"],"yoast_head":"\nArdian acquires majority stake in natural therapies provider INULA - FYB Financial Yearbook<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ardian acquires majority stake in natural therapies provider INULA - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Paris \u2014 Ardian, one of the worl\u00add\u2019s leading inde\u00adpen\u00addent invest\u00adment firms, has ente\u00adred into an agree\u00adment to acquire a majo\u00adrity stake in Inula Group with Vendis Capi\u00adtal, Domi\u00adni\u00adque Baudoux (Foun\u00adder and Chair\u00adman) and Sergio Calan\u00addri (CEO). The Inula Group was formed from the merger of Pran\u00adar\u00f4m and Herbal\u00adGem, two pioneers in the field of natu\u00adral […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2018-10-11T10:42:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/04\/a-ardian.png\" \/>\n\t<meta property=\"og:image:width\" content=\"224\" \/>\n\t<meta property=\"og:image:height\" content=\"224\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"Ardian acquires majority stake in natural therapies provider INULA\",\"datePublished\":\"2018-10-11T10:42:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/\"},\"wordCount\":1103,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/04\/a-ardian.png\",\"articleSection\":[\"General\",\"Featured\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/\",\"url\":\"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/\",\"name\":\"Ardian acquires majority stake in natural therapies provider INULA - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/04\/a-ardian.png\",\"datePublished\":\"2018-10-11T10:42:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/04\/a-ardian.png\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/04\/a-ardian.png\",\"width\":224,\"height\":224},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ardian acquires majority stake in natural therapies provider INULA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ardian acquires majority stake in natural therapies provider INULA - FYB Financial Yearbook","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/","og_locale":"en_US","og_type":"article","og_title":"Ardian acquires majority stake in natural therapies provider INULA - FYB Financial Yearbook","og_description":"Paris \u2014 Ardian, one of the worl\u00add\u2019s leading inde\u00adpen\u00addent invest\u00adment firms, has ente\u00adred into an agree\u00adment to acquire a majo\u00adrity stake in Inula Group with Vendis Capi\u00adtal, Domi\u00adni\u00adque Baudoux (Foun\u00adder and Chair\u00adman) and Sergio Calan\u00addri (CEO). The Inula Group was formed from the merger of Pran\u00adar\u00f4m and Herbal\u00adGem, two pioneers in the field of natu\u00adral […]","og_url":"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2018-10-11T10:42:17+00:00","og_image":[{"width":224,"height":224,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/04\/a-ardian.png","type":"image\/png"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"Ardian acquires majority stake in natural therapies provider INULA","datePublished":"2018-10-11T10:42:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/"},"wordCount":1103,"commentCount":0,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/04\/a-ardian.png","articleSection":["General","Featured","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/","url":"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/","name":"Ardian acquires majority stake in natural therapies provider INULA - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/04\/a-ardian.png","datePublished":"2018-10-11T10:42:17+00:00","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/04\/a-ardian.png","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2018\/04\/a-ardian.png","width":224,"height":224},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/ardian-acquires-majority-stake-in-natural-therapies-provider-inula\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"Ardian acquires majority stake in natural therapies provider INULA"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/42461","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=42461"}],"version-history":[{"count":0,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/42461\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/42175"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=42461"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=42461"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=42461"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}